30542302|t|Genetic Variants of the Brain-Derived Neurotrophic Factor and Metabolic Indices in Veterans With Posttraumatic Stress Disorder.
30542302|a|Posttraumatic stress disorder (PTSD) is a trauma and stressor related disorder that may develop after exposure to an event that involved the actual or possible threat of death, violence or serious injury. Its molecular underpinning is still not clear. Brain-derived neurotrophic factor (BDNF) modulates neuronal processes such as the response to stress, but also weight control, energy and glucose homeostasis. Plasma BDNF levels and a functional BDNF Val66Met (rs6265) polymorphism were reported to be associated with PTSD, as well as with increased body mass index (BMI) and dyslipidaemia in healthy subjects and patients with cardio-metabolic diseases, but these results are controversial. The other frequently studied BDNF polymorphism, C270T (rs56164415), has been associated with the development of different neuropsychiatric symptoms/disorders. As far as we are aware, there are no data on the association of BDNF Val66Met and C270T polymorphisms with metabolic indices in PTSD. Due to high rates of obesity and dyslipidaemia in PTSD, the aim of this study was to elucidate the association of BDNF Val66Met and C270T polymorphisms with BMI and lipid levels in veterans with PTSD. We hypothesized that BDNF variants contribute to susceptibility to metabolic disturbances in PTSD. The study included 333 Caucasian males with combat related PTSD, diagnosed according to DSM-5 criteria. Genotyping of the BDNF Val66Met and C270T polymorphisms was performed using the real-time PCR method. Results were analyzed using hierarchical multiple linear regression and the Mann-Whitney test, with p-value corrected to 0.005. The results showed that BDNF Val66Met and BDNF C270T polymorphisms were not significantly associated with BMI, total cholesterol, LDL-cholesterol, HDL-cholesterol or triglycerides. Although the BDNF C270T polymorphism was nominally associated only with HDL-cholesterol in veterans with PTSD, this significance disappeared after controlling for the effect of age. Namely, slightly higher plasma HDL values in T allele carriers, compared to CC homozygotes, were associated with differences in age. Our results, controlled for the critical covariates, revealed that BDNF Val66Met and C270T were not significantly associated with metabolic indices in veterans with PTSD and that these genetic variants do not contribute to susceptibility to metabolic disturbances in PTSD.
30542302	24	57	Brain-Derived Neurotrophic Factor	Gene	627
30542302	62	71	Metabolic	Disease	MESH:D008659
30542302	97	126	Posttraumatic Stress Disorder	Disease	MESH:D013313
30542302	128	157	Posttraumatic stress disorder	Disease	MESH:D013313
30542302	159	163	PTSD	Disease	MESH:D013313
30542302	170	206	trauma and stressor related disorder	Disease	MESH:D000068099
30542302	298	303	death	Disease	MESH:D003643
30542302	305	313	violence	Disease	
30542302	325	331	injury	Disease	MESH:D014947
30542302	380	413	Brain-derived neurotrophic factor	Gene	627
30542302	415	419	BDNF	Gene	627
30542302	518	525	glucose	Chemical	MESH:D005947
30542302	546	550	BDNF	Gene	627
30542302	575	579	BDNF	Gene	627
30542302	580	588	Val66Met	ProteinMutation	tmVar:p|SUB|V|66|M;HGVS:p.V66M;VariantGroup:0;CorrespondingGene:627;RS#:6265;CorrespondingSpecies:9606;CA#:127325
30542302	590	596	rs6265	SNP	tmVar:rs6265;VariantGroup:0;CorrespondingGene:627;RS#:6265;CorrespondingSpecies:9606
30542302	647	651	PTSD	Disease	MESH:D013313
30542302	705	718	dyslipidaemia	Disease	
30542302	743	751	patients	Species	9606
30542302	757	782	cardio-metabolic diseases	Disease	MESH:D008659
30542302	850	854	BDNF	Gene	627
30542302	869	874	C270T	DNAMutation	tmVar:c|SUB|C|270|T;HGVS:c.270C>T;VariantGroup:1;CorrespondingGene:627;RS#:56164415;CorrespondingSpecies:9606
30542302	876	886	rs56164415	SNP	tmVar:rs56164415;VariantGroup:1;CorrespondingGene:627;RS#:56164415;CorrespondingSpecies:9606
30542302	943	969	neuropsychiatric symptoms/	Disease	MESH:D001523
30542302	1044	1048	BDNF	Gene	627
30542302	1049	1057	Val66Met	ProteinMutation	tmVar:p|SUB|V|66|M;HGVS:p.V66M;VariantGroup:0;CorrespondingGene:627;RS#:6265;CorrespondingSpecies:9606;CA#:127325
30542302	1062	1067	C270T	DNAMutation	tmVar:c|SUB|C|270|T;HGVS:c.270C>T;VariantGroup:1;CorrespondingGene:627;RS#:56164415;CorrespondingSpecies:9606
30542302	1087	1096	metabolic	Disease	MESH:D008659
30542302	1108	1112	PTSD	Disease	MESH:D013313
30542302	1135	1142	obesity	Disease	MESH:D009765
30542302	1147	1160	dyslipidaemia	Disease	
30542302	1164	1168	PTSD	Disease	MESH:D013313
30542302	1228	1232	BDNF	Gene	627
30542302	1233	1241	Val66Met	ProteinMutation	tmVar:p|SUB|V|66|M;HGVS:p.V66M;VariantGroup:0;CorrespondingGene:627;RS#:6265;CorrespondingSpecies:9606;CA#:127325
30542302	1246	1251	C270T	DNAMutation	tmVar:c|SUB|C|270|T;HGVS:c.270C>T;VariantGroup:1;CorrespondingGene:627;RS#:56164415;CorrespondingSpecies:9606
30542302	1279	1284	lipid	Chemical	MESH:D008055
30542302	1309	1313	PTSD	Disease	MESH:D013313
30542302	1336	1340	BDNF	Gene	627
30542302	1382	1404	metabolic disturbances	Disease	MESH:D024821
30542302	1408	1412	PTSD	Disease	MESH:D013313
30542302	1473	1477	PTSD	Disease	MESH:D013313
30542302	1536	1540	BDNF	Gene	627
30542302	1541	1549	Val66Met	ProteinMutation	tmVar:p|SUB|V|66|M;HGVS:p.V66M;VariantGroup:0;CorrespondingGene:627;RS#:6265;CorrespondingSpecies:9606;CA#:127325
30542302	1554	1559	C270T	DNAMutation	tmVar:c|SUB|C|270|T;HGVS:c.270C>T;VariantGroup:1;CorrespondingGene:627;RS#:56164415;CorrespondingSpecies:9606
30542302	1772	1776	BDNF	Gene	627
30542302	1777	1785	Val66Met	ProteinMutation	tmVar:p|SUB|V|66|M;HGVS:p.V66M;VariantGroup:0;CorrespondingGene:627;RS#:6265;CorrespondingSpecies:9606;CA#:127325
30542302	1790	1794	BDNF	Gene	627
30542302	1795	1800	C270T	DNAMutation	tmVar:c|SUB|C|270|T;HGVS:c.270C>T;VariantGroup:1;CorrespondingGene:627;RS#:56164415;CorrespondingSpecies:9606
30542302	1865	1876	cholesterol	Chemical	MESH:D002784
30542302	1914	1927	triglycerides	Chemical	MESH:D014280
30542302	1942	1946	BDNF	Gene	627
30542302	1947	1952	C270T	DNAMutation	tmVar:c|SUB|C|270|T;HGVS:c.270C>T;VariantGroup:1;CorrespondingGene:627;RS#:56164415;CorrespondingSpecies:9606
30542302	2034	2038	PTSD	Disease	MESH:D013313
30542302	2311	2315	BDNF	Gene	627
30542302	2316	2324	Val66Met	ProteinMutation	tmVar:p|SUB|V|66|M;HGVS:p.V66M;VariantGroup:0;CorrespondingGene:627;RS#:6265;CorrespondingSpecies:9606;CA#:127325
30542302	2329	2334	C270T	DNAMutation	tmVar:c|SUB|C|270|T;HGVS:c.270C>T;VariantGroup:1;CorrespondingGene:627;RS#:56164415;CorrespondingSpecies:9606
30542302	2374	2383	metabolic	Disease	MESH:D008659
30542302	2409	2413	PTSD	Disease	MESH:D013313
30542302	2485	2507	metabolic disturbances	Disease	MESH:D024821
30542302	2511	2515	PTSD	Disease	MESH:D013313
30542302	Association	MESH:D024821	627
30542302	Association	MESH:D005947	627
30542302	Association	MESH:D013313	RS#:6265;HGVS:p.V66M;CorrespondingGene:627
30542302	Association	RS#:56164415;HGVS:c.270C>T;CorrespondingGene:627	MESH:D013313
30542302	Positive_Correlation	RS#:56164415;HGVS:c.270C>T;CorrespondingGene:627	MESH:D001523
30542302	Association	MESH:D013313	627
30542302	Association	MESH:D008659	RS#:6265;HGVS:p.V66M;CorrespondingGene:627
30542302	Association	MESH:D008659	627
30542302	Association	RS#:6265;HGVS:p.V66M;CorrespondingGene:627	MESH:D013313
30542302	Positive_Correlation	MESH:D001523	RS#:56164415;CorrespondingGene:627
30542302	Association	MESH:D001523	627
30542302	Positive_Correlation	RS#:6265;HGVS:p.V66M;CorrespondingGene:627	MESH:D001523
30542302	Association	MESH:D008659	RS#:6265;CorrespondingGene:627
30542302	Association	MESH:D013313	RS#:6265;CorrespondingGene:627
30542302	Association	MESH:D013313	627
30542302	Association	MESH:D001523	627
30542302	Association	MESH:D008659	627

